Incidence and risk factors of cutaneous reactions to the first COVID‐19 booster vaccine

Documenti analoghi

• Algorithms in allergy: Management of allergic reactions to COVID‐19 vaccines
  di: Mary Johnson, et al.
  Pubblicazione: (2024)
• Risk factors for sulfamethoxazole/trimethoprim‐induced severe cutaneous adverse reactions
  di: Kanokkarn Pinyopornpanish, et al.
  Pubblicazione: (2024)
• Exploring recent advances in drugs severe cutaneous adverse reactions immunopathology
  di: Romane Cadot, et al.
  Pubblicazione: (2024)
• Persistent sex and race disparities in United States anaphylaxis mortality from 1999 to 2020
  di: Ingrid Salciccioli, et al.
  Pubblicazione: (2024)
• Global burden of vaccine‐associated angioedema and their related vaccines, 1967–2023: Findings from the global pharmacovigilance database
  di: Yi Deun Jeong, et al.
  Pubblicazione: (2024)